S&P 500 (NYSE:SPY) component DENTSPLY International Inc. (NASDAQ:XRAY) reported net income above Wall Street’s expectations for the second quarter. DENTSPLY International, Inc. manufactures and distributes dental equipment and products, including artificial teeth and dental consumable products.
DENTSPLY International Earnings Cheat Sheet for the Second Quarter
Results: Net income for DENTSPLY International Inc. rose to $74.2 million (52 cents per share) vs. $72.4 million (49 cents per share) in the same quarter a year earlier. This marks a rise of 2.6% from the year earlier quarter.
Revenue: Rose 7.8% to $609.4 million from the year earlier quarter.
Actual vs. Wall St. Expectations: XRAY reported adjusted net income of 55 cents per share. By that measure, the company beat the mean estimate of 51 cents per share. It beat the average revenue estimate of $575.3 million.
Quoting Management: Bret Wise, Chairman and Chief Executive Officer, stated “We are pleased to report record sales and earnings in the second quarter and we are particularly pleased with the early sales performance from a number of new products launched during the first half of the year.Although our results have been negatively impacted by the supply outage of orthodontic products sourced from Japan, we continue to execute our contingency plans to mitigate the impact on both our near-term and long-term results.”
The company has now topped analyst estimates for the last three quarters. It beat the mark by one cent in the first quarter and by one cent in the fourth quarter of the last fiscal year.
The company’s revenue has now risen for two straight quarters. In the first quarter, revenue increased 4.5% to $570.5 million from the year earlier quarter.
The company has now seen net income rise in two straight quarters. In the first quarter, net income rose 11.7% from the year earlier.
Gross margins grew 0.8 percentage point to 51.7%. The growth seemed to be driven by increased revenue, as the figure rose 7.8% from the year earlier quarter while costs rose 6.2%.
Competitors to Watch: Young Innovations, Inc. (NASDAQ:YDNT), Align Technology, Inc. (NASDAQ:ALGN), Sirona Dental Systems, Inc. (NASDAQ:SIRO), Biolase Technology, Inc. (NASDAQ:BLTI), Pro-Dex, Inc. (NASDAQ:PDEX), Danaher Corporation (NYSE:DHR), Integra LifeSciences Hldgs. Corp. (NASDAQ:IART), 3M Company (NYSE:MMM), Cantel Medical Corp. (NYSE:CMN), and Zimmer Holdings, Inc. (NYSE:ZMH).
(Source: Xignite Financials)